CAHIR
Technology Solutions
Our AI technology procurement framework creates ROI through avoided loss, faster value capture, and reusable governance assets. d your business motto by double clicking
1. Reduce risk
Screen out weak-fit solutions before capital is committed.
Avoided loss: fewer failed deployments, fewer hidden-cost contracts, lower remediation risk.
2. Improve decisions
Align clinical, IT, compliance, operations, and finance around one evidence base.
Growth & value: faster confident decisions and stronger realization of clinical and operational benefits.
3. Preserve value
Monitor performance, equity, and vendor accountability after go-live.
Sustainability: governance assets that support future procurements at lower marginal effort.
Comprehensive Procurement Evaluation Framework
5
Advisory phases spanning readiness through post-deployment oversight
40/35/25
Weighted clinical, technical, and operational scoring model
100
Point Procurement Readiness Score to guide evidence-based decisions
Advisory Product
With a device's full lifecycle in mind, we have developed a five-phase structured advisory system for readiness, vendor assessment, scoring, pilot execution, and ongoing surveillance across clinical, technical, and operational domains.
1. Governance Readiness
Committee formation, readiness assessment, and policy design.
2. Market Assessment
Use case prioritization, evidence review, and vendor screening.
3. Evaluation & Scoring
Clinical, technical, and operational scoring for procurement decisions.
4. Pilot & Decision
Real-world pilot oversight, final PRS, and negotiation support.
5. Post-Deployment
Monitoring, governance reviews, incident response, and lifecycle accountability.
AI Device Procurement Advisory
Full lifecycle support from governance readiness and vendor market scans through pilot monitoring, final procurement recommendation, and contract review. Sample Deliverables:
- Governance committee design and stakeholder RACI alignment
- Vendor landscape mapping and shortlist development
- Composite Procurement Readiness Score and executive recommendation memo
Market Landscape &
Vendor Assessment
CAHIR facilitates a systematic scan of the AI device market and structured vendor engagement. This phase generates a vetted vendor shortlist aligned to the institution's clinical priorities and governance criteria. Sample Deliverables:
-
AI Use Case Priority Matrix (ranked by clinical impact, feasibility, and equity)
-
Evidence Summary Sheets per priority use case
-
Regulatory Pathway Summary (FDA classification and clearance status)
Regulatory Strategy & Alignment
Specialized support for FDA-aligned procurement strategy, NIST AI RMF adoption, HIPAA compliance, and interoperability planning. Sample Deliverables:
- Post-Deployment Monitoring Dashboard (template)
- FDA, ONC, and cybersecurity alignment checkpoints
- Custom governance dashboards and post-deployment monitoring protocols
Dynamic & versatile evaluation & scoring that brings measurable impact to AI procurement fast.
CAHIR translates complex procurement questions into a structured, weighted decision model with measurable benefits that can be harnessed across industry. We provide in-depth expertise for Phase 3 of the advisory system: comprehensive evaluation and scoring. Our evaluation approach uses a weighted scoring model across 3 domains with clear and user-friendly scoring rubrics. Domain scores are weighted and combined into a composite Procurement Readiness Score (PRS).
PRS Interpretation: 85–100 = Recommended for Procurement | 70–84 = Conditional Approval (address gaps) | 55–69 = Hold — Significant Remediation Required | Below 55 = Do Not Procure
Health systems need more than AI vendor demos.
They need a structured and clear approach to successful procurement and adoption.
